Tracy-Ann Moo1, Kate R Pawloski1, Varadan Sevilimedu2, Jillian Charyn1, Brett A Simon3,4, Lisa M Sclafani1, George Plitas1, Andrea V Barrio1, Laurie J Kirstein1, Kimberly J Van Zee1, Monica Morrow5. 1. Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 2. Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 3. Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 4. Josie Robertson Surgery Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 5. Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. morrowm@mskcc.org.
Abstract
BACKGROUND: Whether routinely prescribed opioids are necessary for pain control after discharge among lumpectomy/sentinel node biopsy (Lump/SLNB) patients is unclear. We hypothesize that Lump/SLNB patients could be discharged without opioids, with a failure rate < 10%. This study prospectively examines outcomes after changing standard discharge prescription from an opioid/non-steroidal anti-inflammatory drug (NSAID) to NSAID/acetaminophen. PATIENTS AND METHODS: Standard discharge pain medication orders included opioids in the first 3-month study period and were changed to NSAID/acetaminophen in the second 3-month period. Patient-reported medication consumption and pain scores were collected by post-discharge survey. Frequency of discharge with opioid, NSAID/acetaminophen failure rate, opioid use, and pain scores were examined. RESULTS: From May to October 2019, 663 patients had Lump/SLNB: 371 in the opioid study period and 292 in the NSAID period. In the opioid period, 92% (342/371) of patients were prescribed an opioid at discharge; of 142 patients who documented opioid use on the survey, 86 (61%) used zero tablets. Among 56 (39%) patients who used opioids, the median number taken by POD 5 was 4. After the change to NSAID/acetaminophen, rates of opioid prescription decreased to 14% (41/292). The NSAID/acetaminophen failure rate was 2% (5/251). Among survey respondents, there was no significant difference in the maximum reported pain scores (POD 1-5) between the opioid period and the NSAID period (p = 0.7). CONCLUSIONS: In Lump/SLNB patients, a change to default discharge with NSAID/acetaminophen resulted in a 78% absolute reduction in opioid prescription, with a failure rate of 2% and no difference in patient-reported pain scores. Most Lump/SLNB patients can be discharged with NSAID/acetaminophen.
BACKGROUND: Whether routinely prescribed opioids are necessary for pain control after discharge among lumpectomy/sentinel node biopsy (Lump/SLNB) patients is unclear. We hypothesize that Lump/SLNB patients could be discharged without opioids, with a failure rate < 10%. This study prospectively examines outcomes after changing standard discharge prescription from an opioid/non-steroidal anti-inflammatory drug (NSAID) to NSAID/acetaminophen. PATIENTS AND METHODS: Standard discharge pain medication orders included opioids in the first 3-month study period and were changed to NSAID/acetaminophen in the second 3-month period. Patient-reported medication consumption and pain scores were collected by post-discharge survey. Frequency of discharge with opioid, NSAID/acetaminophen failure rate, opioid use, and pain scores were examined. RESULTS: From May to October 2019, 663 patients had Lump/SLNB: 371 in the opioid study period and 292 in the NSAID period. In the opioid period, 92% (342/371) of patients were prescribed an opioid at discharge; of 142 patients who documented opioid use on the survey, 86 (61%) used zero tablets. Among 56 (39%) patients who used opioids, the median number taken by POD 5 was 4. After the change to NSAID/acetaminophen, rates of opioid prescription decreased to 14% (41/292). The NSAID/acetaminophen failure rate was 2% (5/251). Among survey respondents, there was no significant difference in the maximum reported pain scores (POD 1-5) between the opioid period and the NSAID period (p = 0.7). CONCLUSIONS: In Lump/SLNB patients, a change to default discharge with NSAID/acetaminophen resulted in a 78% absolute reduction in opioid prescription, with a failure rate of 2% and no difference in patient-reported pain scores. Most Lump/SLNB patients can be discharged with NSAID/acetaminophen.
Authors: Mayo H Fujii; Ashley C Hodges; Ruby L Russell; Kristin Roensch; Bruce Beynnon; Thomas P Ahern; Peter Holoch; Jesse S Moore; S Elizabeth Ames; Charles D MacLean Journal: J Am Coll Surg Date: 2018-02-28 Impact factor: 6.113
Authors: Kristin E Rojas; Donna-Marie Manasseh; Peter L Flom; Solomon Agbroko; Nicole Bilbro; Charusheela Andaz; Patrick I Borgen Journal: Breast Cancer Res Treat Date: 2018-06-18 Impact factor: 4.872
Authors: Roshni Rao; Rubie Sue Jackson; Barry Rosen; David Brenin; Wendy Cornett; Oluwadamilola M Fayanju; Steven L Chen; Negar Golesorkhi; Kandice Ludwig; Ayemoethu Ma; Starr Koslow Mautner; Michelle Sowden; Lee Wilke; Barbara Wexelman; Sarah Blair; Monique Gary; Stephen Grobmyer; E Shelley Hwang; Ted James; Nimmi S Kapoor; Jaime Lewis; Ingrid Lizarraga; Megan Miller; Heather Neuman; Shayna Showalter; Linda Smith; Joshua Froman Journal: Ann Surg Oncol Date: 2020-01-21 Impact factor: 5.344
Authors: Rebecca E Scully; Andrew J Schoenfeld; Wei Jiang; Stuart Lipsitz; Muhammad Ali Chaudhary; Peter A Learn; Tracey Koehlmoos; Adil H Haider; Louis L Nguyen Journal: JAMA Surg Date: 2018-01-01 Impact factor: 14.766
Authors: Josh Bleicher; Zachary Fender; Jordan E Johnson; Brian T Cain; Kathy Phan; Damien Powers; Guo Wei; Angela P Presson; Alvin Kwok; T Bartley Pickron; Courtney L Scaife; Lyen C Huang Journal: Am J Surg Date: 2021-12-22 Impact factor: 3.125
Authors: Kate R Pawloski; Regina Matar; Varadan Sevilimedu; Audree B Tadros; Laurie J Kirstein; Hiram S Cody; Kimberly J Van Zee; Monica Morrow; Tracy-Ann Moo Journal: Ann Surg Oncol Date: 2021-07-10 Impact factor: 5.344